If you invest in the stock market, you must know the Dr Reddy share price targets for 2025, 2026, 2027, 2028, 2029, and 2030. Here, you will get detailed information regarding all your queries, such as its fundamentals, shareholdings, financial performance, future predictions, and more.
About Dr Reddy’s Laboratories Limited
Dr. Reddy’s Laboratories is a pharmaceutical company of India that makes and sells important medicines used to treat common and serious health problems. It provides affordable generic medicines, OTC drugs, and active pharmaceutical ingredients (APIs) used in hospitals and homes around the world. The company is known for making high-quality cancer, heart, and infection medicines, and also helps bring low-cost treatment options to people in India and other countries. Dr. Reddy’s is trusted for its safe, FDA-approved drugs, and is one of the top names in the healthcare and pharma industry.
Fundamental Analysis of Dr Reddy
| Market Cap | ₹1,08,662.55 Cr. |
| ROE | 20.25% |
| ROCE | 25.60% |
| P/E | 15.76 |
| P/B | 3.43 |
| Div. Yield | 0.61% |
| Book Value | ₹379.51 |
| Face Value | ₹1 |
| 52-Week High | ₹1,420.20 |
| 52-Week Low | ₹1,025.90 |
Also Read: Wockhardt Pharma Share Price Target 2025 to 2030
Dr Reddy Share Price Target Tomorrow
Dr Reddy Share Price Target 2025
After analysing past price trends and market performance, it is estimated that the Dr Reddy stock price could reach a minimum of ₹1250 and potentially achieve a maximum target of ₹1350 in the year 2025.
| Year 2025 | Target Price |
|---|---|
| Starting Price | ₹1250 |
| Ending Price | ₹1350 |
Dr Reddy Share Price Target 2026
After analysing past price trends and market performance, it is estimated that the Dr Reddy stock price could reach a minimum of ₹1400 and potentially achieve a maximum target of ₹1550 in the year 2026.
| Year 2026 | Target Price |
|---|---|
| Starting Price | ₹1400 |
| Ending Price | ₹1550 |
Dr Reddy Share Price Target 2027
After analysing past price trends and market performance, it is estimated that the Dr Reddy stock price could reach a minimum of ₹1600 and potentially achieve a maximum target of ₹1800 in the year 2027.
| Year 2027 | Target Price |
|---|---|
| Starting Price | ₹1600 |
| Ending Price | ₹1800 |
Dr Reddy Share Price Target 2028
After analysing past price trends and market performance, it is estimated that the Dr Reddy stock price could reach a minimum of ₹1850 and potentially achieve a maximum target of ₹2000 in the year 2028.
| Year 2028 | Target Price |
|---|---|
| Starting Price | ₹1850 |
| Ending Price | ₹2000 |
Dr Reddy Share Price Target 2029
After analysing past price trends and market performance, it is estimated that the Dr Reddy stock price could reach a minimum of ₹2000 and potentially achieve a maximum target of ₹3000 in the year 2029.
| Year 2029 | Target Price |
|---|---|
| Starting Price | ₹2000 |
| Ending Price | ₹3000 |
Dr Reddy Share Price Target 2030
After analysing past price trends and market performance, it is estimated that the Dr Reddy stock price could reach a minimum of ₹2500 and potentially achieve a maximum target of ₹4000 in the year 2030.
| Year 2030 | Target Price |
|---|---|
| Starting Price | ₹3000 |
| Ending Price | ₹4000 |
Also Read: Glenmark Pharmaceuticals Share Price Target & Forecast 2025 to 2030
Shareholding Pattern of Dr Reddy
| Retail & Others | 10.27% |
| Promoters | 26.64% |
| Foreign Institutions | 36.36% |
| Mutual Funds | 13.61% |
| Other Domestic Institutions | 13.13% |
Key Competitors of Dr Reddy
Key competitors or peer companies of Dr Reddy are Sun Pharmaceutical Industries, Cipla, Lupin, Aurobindo Pharma, Torrent Pharmaceuticals, Glenmark Pharmaceuticals, Zydus Lifesciences, Biocon, Cadila Pharmaceuticals, Alkem Laboratories, Divi’s Laboratories, Wockhardt, Natco Pharma, Jubilant Pharmova, and Alembic Pharmaceuticals.
FAQs
Q. What is the price target for Dr Reddy in 2025?
The price target for Dr Reddy in 2025 is projected to range from ₹1250 to ₹1350.
Q. What is the price target for Dr Reddy in 2030?
The price target for Dr Reddy in 2030 is projected to range from ₹3000 to ₹4000.
Q. Is Dr Reddy Ltd a debt-free company?
Yes, Dr Reddy Ltd is a debt-free company.
Q. Who is the CEO of Dr Reddy Ltd?
The CEO of Dr Reddy Ltd is Erez Israeli.
Disclaimer: All the information provided in this article is for educational purposes only. DateUpdateGo always advises seeking guidance from a certified financial advisor before making any investment-related decisions.
We have more than 5 years of experience in stock market and analysis, and we are dedicated to delivering accurate, real-time market updates and insightful analysis. With a sharp eye on the Indian and global stock markets, we simplify complex financial data and trends to help investors make informed decisions.
